Last reviewed · How we verify
Complicated E. Coli Peritonitis
Approved treatments
- Maxipime · Baxter
Cefepime is a cephalosporin antibacterial drug. - Maxipime · Baxter
Cefepime is a cephalosporin antibacterial drug that inhibits bacterial cell wall synthesis. - Cefepim · University Hospital Tuebingen
- Ciprofloxacine · Poitiers University Hospital
- Invanz · Merck & Co.
Invanz works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death. - Noroxin
- Floxin
- Cipro · Bayer AG
- Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Complicated E. Coli Peritonitis patent landscape — cliff calendar, originator estates, attackable patents
- Complicated E. Coli Peritonitis treatment landscape brief
- Complicated E. Coli Peritonitis treatment updates RSS
Frequently asked questions about Complicated E. Coli Peritonitis
What drugs treat Complicated E. Coli Peritonitis?
Tracked treatments include Maxipime, Cefepim, Ciprofloxacine, Invanz, Noroxin, Floxin, Cipro, Ofloxacine.
What is the treatment for Complicated E. Coli Peritonitis?
Standard treatment for Complicated E. Coli Peritonitis includes Maxipime, Cefepim, Ciprofloxacine, Invanz, Noroxin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Complicated E. Coli Peritonitis patent cliff · Complicated E. Coli Peritonitis CI report
- Treatment: Maxipime · Baxter
- Treatment: Maxipime · Baxter
- Treatment: Cefepim · University Hospital Tuebingen
- Treatment: Ciprofloxacine · Poitiers University Hospital
- Treatment: Invanz · Merck & Co.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing